UBS Group’s MGC Diagnostics Corporation MGCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,418
| Closed | -$27K | – | 8549 |
|
|
2017
Q4 | $27K | Buy |
+2,418
| New | +$23.3K | ﹤0.01% | 6345 |
|
|
2017
Q3 | – | Sell |
-775
| Closed | -$6K | – | 8258 |
|
|
2017
Q2 | $6K | Sell |
775
-23
| -3% | -$189 | ﹤0.01% | 7082 |
|
|
2017
Q1 | $7K | Buy |
+798
| New | +$7.04K | ﹤0.01% | 6863 |
|
|
2016
Q4 | – | Sell |
-1,776
| Closed | -$12K | – | 8294 |
|
|
2016
Q3 | $12K | Sell |
1,776
-592
| -25% | -$4.09K | ﹤0.01% | 6691 |
|
|
2016
Q2 | $15K | Sell |
2,368
-1,781
| -43% | -$10.6K | ﹤0.01% | 6541 |
|
|
2016
Q1 | $25K | Buy |
+4,149
| New | +$27.3K | ﹤0.01% | 6048 |
|
|
2015
Q4 | – | Sell |
-40
| Closed | – | – | 8748 |
|
|
2015
Q3 | $0 | Sell |
40
-1,118
| -97% | -$6.37K | ﹤0.01% | 8857 |
|
|
2015
Q2 | $7K | Sell |
1,158
-204
| -15% | -$1.27K | ﹤0.01% | 7735 |
|
|
2015
Q1 | $10K | Buy |
1,362
+496
| +57% | +$3.45K | ﹤0.01% | 7668 |
|
|
2014
Q4 | $6K | Buy |
+866
| New | +$5.65K | ﹤0.01% | 8896 |
|
UBS Group's MGCD Position: Q1 2018 in Review
UBS Group sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 2,418 shares — an estimated $27K sold.
UBS Group first reported a position in MGCD in Q4 2014 and held it in 10 quarters. The position peaked at $27K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.
- UBS Group reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
- UBS Group sold 2,418 MGC Diagnostics Corporation shares in Q1 2018, an estimated $27K.
- UBS Group first reported a position in MGC Diagnostics Corporation in Q4 2014 and held it in 10 quarters.
- UBS Group's MGC Diagnostics Corporation position peaked at $27K in Q4 2017.
- 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.